{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T05:54:24Z","timestamp":1773294864017,"version":"3.50.1"},"reference-count":52,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2012,1,6]],"date-time":"2012-01-06T00:00:00Z","timestamp":1325808000000},"content-version":"vor","delay-in-days":1345,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["accpjournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacotherapy"],"published-print":{"date-parts":[[2008,5]]},"abstract":"<jats:p>\n                    An estimated 70\u201387% of patients who suffer from posttraumatic stress disorder (PTSD) experience sleep disruption. These patients have distressing dreams or nightmares in which the traumatic event is reexperienced, and they also have difficulty in falling or staying asleep. Selective serotonin reuptake inhibitors are the treatment of choice for PTSD, but with the exception of fluvoxamine, they are often ineffective or only partially effective for sleep problems. Sedative\u2010hypnotics may be helpful in the short term but are associated with tolerance and addiction potential. In the central nervous system, \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    \u2010adrenergic receptors are known to be important in both the startle and sleep responses. Stimulation of these receptors may contribute to PTSD\u2010related trauma\u2010content nightmares. Prazosin, a highly lipophilic \u03b1\n                    <jats:sub>1<\/jats:sub>\n                    \u2010adrenergic receptor blocker that is traditionally used to treat hypertension and benign prostatic hyperplasia, has been shown to decrease the occurrence of trauma nightmares in both combat veterans and patients with non\u2010combat\u2010related PTSD. The available data, although mostly from open\u2010label trials, suggest that this agent also improves sleep quality and patients' sense of well\u2010being and ability to function in daily activities. The optimum dose is unknown; however, a dose\u2010related response appears to be evident. Clinicians should monitor for orthostatic hypotension, usually seen early in therapy, when prazosin is started in patients with PTSD.\n                  <\/jats:p>","DOI":"10.1592\/phco.28.5.656","type":"journal-article","created":{"date-parts":[[2008,4,30]],"date-time":"2008-04-30T13:28:56Z","timestamp":1209562136000},"page":"656-666","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Prazosin for the Treatment of Posttraumatic Stress Disorder Sleep Disturbances"],"prefix":"10.1002","volume":"28","author":[{"given":"Lisa J.","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,1,6]]},"reference":[{"issue":"7","key":"e_1_2_1_2_2","first-page":"5","article-title":"Posttraumatic stress disorder: epidemiology and health related considerations","volume":"61","author":"Hidalgo RB","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.2.193"},{"key":"e_1_2_1_4_2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0193-953X(18)30113-8","article-title":"Post traumatic stress disorder in the military veteran","volume":"17","author":"Friedman MJ","year":"1994","journal-title":"Clin North Am"},{"key":"e_1_2_1_5_2","unstructured":"American Psychiatric Association.Diagnostic and statistical manual of mental disorders 4th ed text revision. Available fromhttp:www.psychiatryonline.comcontent.aspxaID2016. Accessed April 9 2007."},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3956(02)00025-0"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-36593"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.11.1659"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.152.1.110"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2134(98)00059-3"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10960-004-5796-6"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-7358(03)00032-1"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1993.01820160064008"},{"key":"e_1_2_1_14_2","first-page":"9779","article-title":"Physiological functions of glucocorticoids in stress and their relation to pharmacological actions","volume":"93","author":"Munck A","year":"1984","journal-title":"Endocrinol Rev"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.07.030"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1038\/371702a0"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-7894(86)80097-1"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(99)00219-X"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1990.01810230065010"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4886(77)90123-6"},{"key":"e_1_2_1_21_2","first-page":"313","volume-title":"Neurobiological and clinical consequences of stress: from normal adaptation in PTSD","author":"Woodward SH","year":"1995"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/jts.2490080106"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-1017411"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.12.2043"},{"issue":"16","key":"e_1_2_1_25_2","first-page":"3","article-title":"The expert consensus guideline series: treatment of posttraumatic stress disorder","volume":"60","author":"Fox EB","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(01)01170-2"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200464040-00004"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0006-3223(98)00092-4"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1011100420978"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v64n0415"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2001-15871"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.9.1524-a"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.157.9.1525"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004630-200105000-00005"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.v05n0203"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.jcp.0000169624.37819.60"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.yic.0000185021.48279.00"},{"key":"e_1_2_1_38_2","first-page":"236","article-title":"Core symptoms of post\u2010traumatic stress disorder un\u2010improved by alprazolam treatment","volume":"51","author":"Braun P","year":"1990","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1176\/ps.50.3.421"},{"key":"e_1_2_1_40_2","first-page":"166","volume-title":"Goodman and Gilman's the pharmacological basis of therapeutics","author":"Westfall TC","year":"2006"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00503830"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v61n0208"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200202000-00013"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1177\/0891988703256050"},{"key":"e_1_2_1_45_2","doi-asserted-by":"crossref","first-page":"513","DOI":"10.7205\/MILMED.170.6.513","article-title":"Clinical case series: the use of prazosin for combat\u2010related recurrent nightmares among operation Iraq freedom combat veterans","volume":"6","author":"Daly CM","year":"2005","journal-title":"Mil Med"},{"key":"e_1_2_1_46_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0705"},{"key":"e_1_2_1_47_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.160.2.371"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopsych.2006.06.032"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/0165-1781(89)90047-4"},{"key":"e_1_2_1_50_2","unstructured":"United States National Institutes of Health.Efficacy of sleep interventions for PTSD. Available fromhttp:www.clinicaltrials.govctshowNCT00393874order1. Accessed February 21 2008."},{"key":"e_1_2_1_51_2","unstructured":"United States National Institutes of Health.Trial of prazosin versus paroxetine in combat stress\u2010related post\u2010traumatic stress disorder (PTSD) nightmares and sleep disturbance. Available fromhttp:www.clinicaltrials.govctshowNCT00202449order4. Accessed February 21 2008."},{"key":"e_1_2_1_52_2","unstructured":"United States National Institutes of Health.Prazosin for treating noncombat trauma post\u2010traumatic stress disorder. Available fromhttp:www.clinicaltrials.govctshowNCT00183430order6. Accessed February 21 2008."},{"key":"e_1_2_1_53_2","unstructured":"United States National Institutes of Health.Prazosin and combat trauma PTSD (PACT). Available fromhttp:www.clinicaltrials.govct2showNCT00532493termprazosinandptsd&rank1. Accessed February 21 2008.\u00e5."}],"container-title":["Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1592%2Fphco.28.5.656","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1592\/phco.28.5.656","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T17:56:37Z","timestamp":1761069397000},"score":1,"resource":{"primary":{"URL":"https:\/\/accpjournals.onlinelibrary.wiley.com\/doi\/10.1592\/phco.28.5.656"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":52,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["10.1592\/phco.28.5.656"],"URL":"https:\/\/doi.org\/10.1592\/phco.28.5.656","archive":["Portico"],"relation":{},"ISSN":["0277-0008","1875-9114"],"issn-type":[{"value":"0277-0008","type":"print"},{"value":"1875-9114","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]},"assertion":[{"value":"2012-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}